References
- McDonald P C, Rombout R P, Siiteri P K. Plasma precursors of estrogen. I. Extent of conversion of plasma androstendione to estrone in normal males and in nonpregnant normal, castrate, and adrenalectomized females. J Clin Endocrinol Metab 1967; 27: 1103–7
- Grodin J M, Siiteri P K, McDonald P C. Source of estrogen production in postmenopausal women. J Clin Endocrinol Metab 1973; 36: 207–14
- Santner S J, Feil P D, Santen R J. In situ estrogen production via the estrone sulfatase pathway in breast tumours: relative importance versus the aromatase pathway. J Clin Endocrinol Metab 1984; 59: 29–33
- Ruder H J, Loriaux L, Lipsett M B. Estrone-sulfate: production rate and metabolism in man. J Clin Invest 1972; 51: 1020–33
- Samojlik E, Santen R J, Worgul T J. Plasma estrone-sulfate assessment of reduced estrogen production during treatment of metastatic breast carcinoma. Steroids 1982; 39: 497–507
- Lønning P E, Johannessen D C, Thorsen T, Ekse D. Alterations in plasma estrone-sulfate not caused by aromatase inhibition in breast cancer patients receiving aminoglutethimide treatment. J Steroid Biochem 1989, (Accepted for publication)
- McNeill J M, Reed M J, Beranek P A, et al. A comparison of the in vivo uptake and metabolism of 3H-estrone and 3H-estradiol by normal breast and breast tumour tissues in postmenopausal women. Int J Cancer 1986; 38: 193–6
- Santen R J, Santner S J, Davis B, et al. Aminoglutethimide inhibits extraglandular estrogen production in postmenopausal women with breast carcinoma. J Clin Endocrinol Metab 1978; 47: 1257–65
- Ayub M, Levell M J. Structure-activity relationship of the inhibition of human placental aromatase by imidazole drugs including ketaconazole. J Steroid Biochem 1988; 31: 65–73
- Shaw M A, Nicholls P J, Smith H J. Aminoglutethimide and ketoconazole: historical perspectives and future prospects. J Steroid Biochem 1988; 31: 137–43
- Santen R J. Methods of novel oestrogen deprivation. Proc. Oestrogens and the Human Breast. Edinburgh 22nd-24th September, 1988
- Steel R E, Mellor L, Sawyer W K, Wasvary J M, Browne L J. In vitro and in vivo studies demonstrating potent and selective estrogen inhibition with the nonsteroidal aromatase inhibitor, CGS 16949A. Steroids 1989, (In press)
- Schieweck K, Bhatnagar A S, Matter A. CGS 16949A, a new nonsteroidal aromatase inhibitor: effects on hormone-dependent and independent tumors in vivo. Cancer Res 1988; 48: 834–8
- Hayward J L, Rubens R D, Carbone P P, Heuson J C, Kumaoka S, Segaloff A. Assessment of response to therapy in advanced breast cancer. Br J Cancer 1977; 35: 292–8
- Lønning P E, Kvinnsland S. Mechanism of action of aminoglutethimide as endocrine therapy of breast cancer. Drugs 1988; 35: 685–710
- Lønning P E, Kvinnsland S, Thorsen T, Ueland P M. Alterations in the metabolism of estrogens during treatment with aminoglutethimide in breast cancer findings: preliminary findings. Clin Pharmacokinet 1987; 13: 393–406